Improving peanut allergy prevention for infants at high risk
Optimizing Equitable Peanut Allergy Prevention among Infants at High Risk of Peanut Allergy
This study is looking at how introducing peanuts to babies at high risk for allergies, like those with severe eczema or egg allergies, can help prevent peanut allergies, and it’s designed to support parents and doctors in making this happen around 4-6 months of age.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10866144 on NIH RePORTER |
What this research studies
This research focuses on preventing peanut allergies in infants who are at high risk, particularly those with severe eczema or egg allergies. It aims to implement early peanut introduction around 4-6 months of age, guided by a decision support tool integrated into electronic health records. The study addresses barriers faced by caregivers and healthcare providers in following current guidelines for peanut allergy prevention. By enhancing adherence to these guidelines, the research seeks to improve health outcomes for vulnerable infants.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants aged 0-11 months who are considered high-risk for peanut allergies due to conditions like severe eczema or egg allergies.
Not a fit: Patients who do not have a high risk of developing peanut allergies or those older than 11 months may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of peanut allergies in high-risk infants, improving their quality of life.
How similar studies have performed: Previous research has shown success with similar approaches, particularly the use of decision support tools to enhance guideline adherence in pediatric care.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Flom, Julie — Yale University
- Study coordinator: Flom, Julie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.